Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Home Health Care Serv Q ; 43(3): 191-204, 2024.
Article in English | MEDLINE | ID: mdl-38190733

ABSTRACT

Dementia is a chronic disorder of the brain that affects cognitive performance. The caregivers of individuals with dementia experience a greater burden that affects their Quality of Life (QoL). This cross-sectional study conducted in India was designed to assess the caring burden and QoL among the caregivers of people with dementia, as well as to ascertain the relationship between QoL scores and burden. Our sample included 80 caregivers of people with dementia. Most of the caregivers (n = 59, 73.8%) had a higher level of caregiver burden. There was a negative correlation between caregiver burden scores and QoL. A higher level of caregiver stress and low QoL were experienced by caregivers of dementia patients. In developing countries like India, counseling, and education on home health care for people with dementia should be provided to reduce the burden and enhance the QoL of caregivers.


Subject(s)
Caregivers , Dementia , Quality of Life , Humans , Cross-Sectional Studies , Male , Female , Quality of Life/psychology , Dementia/psychology , Middle Aged , Caregivers/psychology , Caregivers/statistics & numerical data , India , Aged , Adult , Surveys and Questionnaires , Caregiver Burden/psychology , Aged, 80 and over , Cost of Illness , Stress, Psychological/psychology
2.
Asian J Psychiatr ; 73: 103132, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35533602

ABSTRACT

BACKGROUND: Treatment-resistant schizophrenia (TRS) is a substantial burden to patients, caregivers, and the treating team. There is a lack of robust evidence to support the efficacy of various pharmacological and non-pharmacological measures to augment clozapine in this population. When used in conjunction with clozapine or other combination antipsychotic regimens, maintenance electroconvulsive therapy (M-ECT) can be a potential therapeutic option in preventing symptom exacerbation in TRS. However, there is limited evidence supporting the role of M-ECT in TRS. AIM: To evaluate the efficacy and safety of maintenance electroconvulsive therapy in patients with TRS. METHODOLOGY: Sociodemographic details, illness characteristics, details of M-ECT procedure, adverse events, and course of the illness were evaluated using a retrospective chart review at a tertiary care psychiatry centre in south India. Scores on Clinical Global Impression-Severity (CGI-S), Social and Occupational Functioning Assessment Scale (SOFAS), and Hindi Mental Status Examination were compared before and after the course of M-ECT. RESULTS: Seven male and three female patients received M-ECT in the last eight years (range of 22-172 sessions). There was a reduction in hospitalizations for acute exacerbation and significant improvement in the patient's overall functioning without significant adverse effects. CONCLUSION: Maintenance ECT can be a safe and effective treatment option for achieving symptom control in the long-term management of refractory schizophrenia. Controlled trials are needed in this area for further evidence.


Subject(s)
Antipsychotic Agents , Clozapine , Electroconvulsive Therapy , Schizophrenia , Antipsychotic Agents/adverse effects , Clozapine/therapeutic use , Combined Modality Therapy , Electroconvulsive Therapy/adverse effects , Electroconvulsive Therapy/methods , Female , Humans , Male , Retrospective Studies , Schizophrenia/drug therapy , Schizophrenia, Treatment-Resistant , Treatment Outcome
3.
Asian J Psychiatr ; 73: 103102, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35452965

ABSTRACT

BACKGROUND: Schizophrenia is a disabling mental illness. Antipsychotic treatment in conjunction with comprehensive psychosocial rehabilitation services is essential in promoting functional recovery. Assertive Community Treatment (ACT) is an evidence-based approach in promoting recovery in schizophrenia. The evidence for the effectiveness and feasibility of such community-based assertive interventions in low and middle-income countries is limited. AIM: To evaluate the effectiveness of modified assertive community treatment in a South Indian setting and evaluate the perspectives of patients and caregivers who participated in the program. METHODOLOGY: Socio-demographic details, illness characteristics, course of the illness including the number of relapses and hospitalization, adherence level at baseline, the scores on the Social and Occupational Functioning Assessment Scale (SOFAS), and Global disability score on Indian Disability Evaluation and Assessment Scale (IDEAS) were compared before and after the initiation of the M-CAT program using retrospective file review. The perspectives of the clients were assessed using a 6-item questionnaire. RESULTS: Ten patients (six male and four female) with a diagnosis of schizophrenia were under the Manipal Assertive Community Treatment (M-ACT) program for a median duration of 3 years (IQR 1.25) participated in the study. There was a significant improvement in the overall level of functioning, medication adherence, relapse rates, and disability after the enrolment into the program. The majority of the respondents had a positive attitude towards the M-ACT program. CONCLUSION: Assertive community interventions with suitable modifications for local resource-limited conditions may be an effective option in promoting functional recovery in Schizophrenia.


Subject(s)
Antipsychotic Agents , Community Mental Health Services , Schizophrenia , Antipsychotic Agents/therapeutic use , Female , Hospitalization , Humans , Male , Retrospective Studies , Schizophrenia/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...